PIEZOELECTRICITY, ITS HISTORY AND APPLICATIONS = LA PIEZOELECTRICITE, SON HISTOIRE ET SES APPLICATIONSMASON WARREN P.1981; J. ACOUST. SOC. AM.; ISSN 0001-4966; USA; DA. 1981-12; VOL. 70; NO 6; PP. 1561-1566; BIBL. 12 REF.; ILL.Article

Progress in clinical neurosciences: Advances in the management of low-grade gliomasMASON, Warren P.Canadian journal of neurological sciences. 2005, Vol 32, Num 1, pp 18-26, issn 0317-1671, 9 p.Article

Radiation-induced glioma presenting as diffuse leptomeningeal gliomatosis: a case reportHILL, Michael D; MACKENZIE, Ian; MASON, Warren P et al.Journal of neuro-oncology. 2001, Vol 55, Num 2, pp 113-116, issn 0167-594XArticle

Invited Article : The expanding impact of molecular biology on the diagnosis and treatment of gliomasMASON, Warren P; CAIRNCROSS, J. Gregory.Neurology. 2008, Vol 71, Num 5, pp 365-373, issn 0028-3878, 9 p.Article

Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed GlioblastomaCHINOT, Olivier L; WICK, Wolfgang; BRANDES, Alba A et al.The New England journal of medicine. 2014, Vol 370, Num 8, pp 709-722, issn 0028-4793, 14 p.Article

Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial GlioblastomaWICK, Wolfgang; PUDUVALLI, Vinay K; LIEPA, Astra M et al.Journal of clinical oncology. 2010, Vol 28, Num 7, pp 1168-1174, issn 0732-183X, 7 p.Article

An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitisJAECKLE, Kurt A; BATCHELOR, Tracy; ROGERS, Lisa et al.Journal of neuro-oncology. 2002, Vol 57, Num 3, pp 231-239, issn 0167-594XArticle

Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent GlioblastomaBATCHELOR, Tracy T; MULHOLLAND, Paul; DEGROOT, John et al.Journal of clinical oncology. 2013, Vol 31, Num 26, pp 3212-3218, issn 0732-183X, 7 p.Article

A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlationTHIESSEN, Brian; STEWART, Clinton; EISENHAUER, Elizabeth et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 5, pp 353-361, issn 0344-5704, 9 p.Article

Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trialRENI, Michele; MASON, Warren; PACE, Andrea et al.European journal of cancer (1990). 2004, Vol 40, Num 11, pp 1682-1688, issn 0959-8049, 7 p.Article

Radiotherapy and temozolomide for newly diagnosed glioblastoma : Recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 Phase III randomized trialMIRIMANOFF, René-Olivier; GORLIA, Thierry; CAIRNCROSS, Gregory et al.Journal of clinical oncology. 2006, Vol 24, Num 16, pp 2563-2569, issn 0732-183X, 7 p.Article

MGMT gene silencing and benefit from temozolomide in glioblastomaHEGI, Monika E; DISERENS, Annie-Claire; BROMBERG, Jacoline E. C et al.The New England journal of medicine. 2005, Vol 352, Num 10, pp 997-1003, issn 0028-4793, 7 p.Article

Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratomaVITALIANI, Roberta; MASON, Warren; ANCES, Beau et al.Annals of neurology. 2005, Vol 58, Num 4, pp 594-604, issn 0364-5134, 11 p.Article

Upfront Observation Versus Radiation for Adult Pilocytic AstrocytomaISHKANIAN, Adrian; LAPERRIERE, Normand J; WEI XU et al.Cancer. 2011, Vol 117, Num 17, pp 4070-4079, issn 0008-543X, 10 p.Article

USE OF TEMOZOLOMIDE IN AGGRESSIVE PITUITARY TUMORS : CASE REPORT. CommentariesMOHAMMED, Safraz; KOVACS, Kalman; MASON, Warren et al.Neurosurgery. 2009, Vol 64, Num 4, pp 773-774, issn 0148-396X, 2 p.Article

Paraneoplastic anti-N-methyl -D -aspartate receptor encephalitis associated with ovarian teratomaDALMAU, Josep; TUZUN, Erdem; MASON, Warren et al.Annals of neurology. 2007, Vol 61, Num 1, pp 25-36, issn 0364-5134, 12 p.Article

Evaluation of proliferative index and cell cycle protein expression in choroid plexus tumors in childrenCARLOTTI, Carlos G; SALHIA, Bodour; WEITZMAN, Sheila et al.Acta neuropathologica. 2002, Vol 103, Num 1, pp 1-10, issn 0001-6322Article

The changing management of low-grade astrocytomas and oligodendrogliomasAGULNIK, Mark; MASON, Warren P.Hematology/oncology clinics of North America. 2006, Vol 20, Num 6, issn 0889-8588, viii, 1249-1266 [19 p.]Article

Management of Malignant Melanoma : Best PracticesSMYLIE, Michael; CLAVEAU, Joël; ALANEN, Kenneth et al.Journal of cutaneous medicine and surgery. 2009, Vol 13, Num 2, pp 55-73, issn 1203-4754, 19 p.Article

Verbal fluency, Trail Making, and Wisconsin Card Sorting Test performance following right frontal lobe tumor resectionDAVIDSON, Patrick S. R; FU QIANG GAO; MASON, Warren P et al.Neuropsychology, development, and cognition. Section A, journal of clinical and experimental neuropsychology. 2008, Vol 30, Num 1, pp 18-32, issn 1380-3395, 15 p.Article

Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningiomaMASON, Warren P; GENTILI, Fred; MACDONALD, David R et al.Journal of neurosurgery. 2002, Vol 97, Num 2, pp 341-346, issn 0022-3085Article

Polymyoclonus, Laryngospasm, and Cerebellar Ataxia Associated With Adenocarcinoma and Multiple Neural Cation Channel AutoantibodiesLIM, Shen-Yang; MASON, Warren P; YOUNG, Nathan P et al.Archives of neurology (Chicago). 2009, Vol 66, Num 10, pp 1285-1287, issn 0003-9942, 3 p.Article

Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: An intent-to-treat analysisABREY, Lauren E; MOSKOWITZ, Craig H; ZELENETZ, Andrew et al.Journal of clinical oncology. 2003, Vol 21, Num 22, pp 4151-4156, issn 0732-183X, 6 p.Article

Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid TumorsKROP, Ian; DEMUTH, Tim; BLACKMAN, Samuel et al.Journal of clinical oncology. 2012, Vol 30, Num 19, pp 2307-2313, issn 0732-183X, 7 p.Article

Page / 2